Cargando…
Ambroxol Hydrochloride Improves Motor Functions and Extends Survival in a Mouse Model of Familial Amyotrophic Lateral Sclerosis
Amyotrophic lateral sclerosis (ALS) is a multifactorial and fatal neurodegenerative disease. Growing evidence connects sphingolipid metabolism to the pathophysiology of ALS. In particular, levels of ceramides, glucosylceramides, and gangliosides are dysregulated in the central nervous system and at...
Autores principales: | Bouscary, Alexandra, Quessada, Cyril, Mosbach, Althéa, Callizot, Noëlle, Spedding, Michael, Loeffler, Jean-Philippe, Henriques, Alexandre |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6692493/ https://www.ncbi.nlm.nih.gov/pubmed/31447678 http://dx.doi.org/10.3389/fphar.2019.00883 |
Ejemplares similares
-
Sphingolipid Metabolism Is Dysregulated at Transcriptomic and Metabolic Levels in the Spinal Cord of an Animal Model of Amyotrophic Lateral Sclerosis
por: Henriques, Alexandre, et al.
Publicado: (2018) -
Skeletal Muscle Metabolism: Origin or Prognostic Factor for Amyotrophic Lateral Sclerosis (ALS) Development?
por: Quessada, Cyril, et al.
Publicado: (2021) -
Inhibition of β-Glucocerebrosidase Activity Preserves Motor Unit Integrity in a Mouse Model of Amyotrophic Lateral Sclerosis
por: Henriques, Alexandre, et al.
Publicado: (2017) -
Combination of acamprosate and baclofen (PXT864) as a potential new therapy for amyotrophic lateral sclerosis
por: Boussicault, Lydie, et al.
Publicado: (2020) -
Amyotrophic lateral sclerosis and denervation alter sphingolipids and up-regulate glucosylceramide synthase
por: Henriques, Alexandre, et al.
Publicado: (2015)